title: [Transurethral microwave thermotherapy for benign prostatic hyperplasia: preliminary clinical results].
abstract: We evaluated the efficacy of high energy transurethral microwave thermotherapy for treating benign prosthetic hyperplasia. During two years 42 patients with benign prostatic hyperplasia were treated with high energy transurethral microwave thermotherapy. It makes 18% of all the patients been treated. Initial evaluation consisted of a history, clinical examination, transrectal prostate ultrasonography, biopsy, PSA and urodynamic investigation with a pressure flow study. At baseline median patient age was 73 years and median prostate size was 68 g. Median 85 W were administered and treatment time 49 min. After the treatment we subjectively noticed that the patients were feeling better. The complaints according IPSS decreased to 42%, the prostate weight - 22%, removed cistostoms 75% patient, after 6 months been operated 7% of the patient. We noticed the following complications: 3 patients macrohematuria, 1 - orchoepidydymitis, 1 - acute retention of the urination. TUMT has some advantages comparing with other. It is the minimal invasion, the procedure is less painful, less hemorrhage, less complicated numbers. This method is not often used, because there are some contraindication. For patients, who need operation, the age is longer, because of the advance of good medicinal therapy. Transurethral hyperthermia represents a safe and promising method to treat benign prostatic hyperplasia, particularly for patient who candidates for conventional surgical approaches because of medical or personal reasons.
authors.affiliation: Vilnius University hospital Santariskiu klinikos, Lithuania.
authors.forename: Leonardas
authors.initials: L
authors.lastname: Radvinauskas
authors.forename: Adomas
authors.initials: A
authors.lastname: Pletkus
authors.forename: Balys
authors.initials: B
authors.lastname: Dainys
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D003972:Diathermy / Q000379:methods; D006801:Humans; D008297:Male; D008872:Microwaves / Q000627:therapeutic use*; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome